Also found in: Dictionary, Thesaurus, Legal, Encyclopedia, Wikipedia.
Related to polycythemia: polycythemia vera, secondary polycythemia


an increase in the total red blood cell mass of the blood; called also erythrocythemia, hypercythemia, and hypererythrocythemia.

There are two distinct forms of the disease: Primary polycythemia (polycythemia vera) is a myeloproliferative disorder of unknown etiology. It is characterized by hyperplasia of the cell-forming tissues of the bone marrow, with resultant elevation of the erythrocyte count and hemoglobin level, and an increase in the number of leukocytes and platelets.

Secondary polycythemia is a physiologic condition resulting from a deficient oxygen supply to the tissues. The body attempts to compensate for the deficiency by manufacturing more hemoglobin and erythrocytes. Living at high altitudes can produce polycythemia, as can severe chronic lung and heart disorders, especially congenital heart defects.

Absolute polycythemia refers to an increase in red cell mass from any cause. Relative polycythemia refers to a loss of plasma volume causing an elevated hematocrit.
Symptoms. The symptoms of primary and secondary polycythemia are much the same. The increased erythrocyte production results in thickening of the blood and an increased tendency toward clotting. The viscosity of the blood limits its ability to flow properly, so that the supply to the brain and other vital tissues is diminished. This may cause sluggishness, irritability, headache, dizziness, fainting, disturbances of sensation in the hands and feet, and a feeling of fullness in the head. There may be episodes of acute pain as spontaneous clots occur in the blood vessels. The spleen becomes enlarged and the smaller veins become more prominent, so that the skin has a bluish hue. The secondary form is often accompanied by enlargement of the tips of the fingers (clubbing).
Treatment. Treatment of polycythemia vera is aimed at reducing the red cell count and decreasing the blood volume. Mild cases can be managed by periodic phlebotomy. More serious cases may require myelosuppressive therapy; interferon and large-dose aspirin therapy may also be used. Research on treatment modalities is ongoing. In secondary polycythemia, successful treatment of the causative illness will relieve the polycythemia.


The presence of an abnormally high number of red blood cells in the circulating blood.
See also: polycythemia.
[hyper- + G. kytos, cell, + haima, blood]


A condition characterized by an abnormally high number of red blood cells in the blood.


A condition marked by an abnormally large number of red blood cells in the circulatory system.


Any ↑ RBC mass. See Relative polycythemia, Secondary polycythemia.
Polycythemia types
Relative RBC mass is above normal but not pathologic. See Relative polycythemia.
Secondary to various physiopathologic mechanisms, usually hypoxia or ↑ erythropoietin secretion
Neoplastic, ie polycythemia vera, see there  . ;.


An abnormal increase in the number of red blood cells.
Synonym(s): erythrocythemia, polycythaemia.
[poly- + G. kytos, cell, + haima, blood]


(pol?e-si-the'me-a) [ poly- + cyto- + -emia]
An excess of red blood cells. In a newborn, it may reflect hemoconcentration due to hypovolemia or prolonged intrauterine hypoxia, or hypervolemia due to intrauterine twin-to-twin transfusion or placental transfusion resulting in delayed clamping of the umbilical cord. Synonym: erythrocytosis

Chuvash polycythemia

An autosomal recessive erythrocytosis in which patients respond to normal oxygen levels as if they were in an hypoxic environment and make more red blood cells than are needed. ASludging of blood, pulmonary hypertension, and vascular infarcts are common sequelae.

relative polycythemia

A relative (rather than an absolute) increase in the number of erythrocytes due to a reduction of plasma volume, e.g., in patients with burns or dehydration.

secondary polycythemia

Polycythemia due to a physiological condition that stimulates erythropoiesis, e.g., lowered oxygen tension in blood.

spurious polycythemia

Gaisböck syndrome.
Enlarge picture
POLYCYTHEMIA VERA: peripheral blood smear in polycythemia vera (X 400)
Enlarge picture

polycythemia vera

A chronic, life-shortening myeloproliferative disorder due to the reproduction of a single stem-cell clone. It is characterized by proliferation or hyperplasia of all bone marrow cells, with an increase in red blood cell mass and hemoglobin concentration that occurs independently of erythropoietin stimulation. Synonym: erythremiaillustration;


Usually occurring between ages 40 and 60 and most common in males with Jewish ancestry, polycythemia seldom affects children or those of African ancestry. Weakness, fatigue, headache, blood clotting, vertigo, tinnitus, irritability, dyspnea, visual disturbances, flushing of face, redness, or ruddy cyanosis, pruritus, ecchymosis, hypertension, epigastric distress, weight loss, and pain in joints or extremities occur commonly. The bone marrow shows uncontrolled, rapid cellular reproduction and maturation (increased cellularity). Peptic ulcers are often reported.


The mainstay of patient care is the reduction in red blood cell mass with recurrent phlebotomy to lower the hematocrit to 45% or less. Vitals signs are monitored during and after phlebotomy, and the patient is provided with oral fluids and protected from orthostatic hypotension. The symptoms and the need to seek medical attention when signs and symptoms of bleeding and thrombus formation occur are explained to the patient. Rest should be balanced with exercise, but the patient should be advised that activity and ambulation help prevent thrombotic complications. Reassurance and support are provided to the patient and family, and opportunities are provided for questions and discussion of concerns. Patients who have a history of blood clotting or very high platelet counts are treated with myelosuppressive drugs, such as hydroxyurea. During myelosuppressive therapy the patient is informed about adverse effects that may occur, assessed for leukopenia and thrombocytopenia, and protective measures are taught and instituted.



A condition characterized by an overabundance of red blood cells.


An abnormal increase in the number of red blood cells.
Synonym(s): erythrocythemia, polycythaemia.
[poly- + G. kytos, cell, + haima, blood]
References in periodicals archive ?
Therefore, we attributed both the hypertension and polycythemia to ischaemic kidney due to compression of the left perirenal collection.
Matro et al., "Novel HIF2A mutations disrupt oxygen sensing, leading to polycythemia, paragangliomas, and somatostatinomas," Blood, vol.
Verstovsek, "Mechanisms of thrombogenesis in polycythemia vera," Blood Reviews, vol.
The combination of polycythemia and PCM is very rare, with most of the cases reported in literature being cases of concurrent PV and PCM [4].
Leukemia kidney infiltration can cause secondary polycythemia by activating hypoxia-inducible factor (HIF) pathway.
Polycythemia vera (PV), idiopathic myelofibrosis (IMF), and essential thrombocytosis (ET) have been traditionally classified under the "the non CML chronic myeloproliferative neoplasms"2 because they share the features: involvement of a multipotent hematopoietic progenitor cell.6 Dominance of the transformed clone over non-transformed hematopoietic progenitor cells.7-9
* Curcumin treatment in curcumin-treated and curcumin + EPO-induced polycythemia groups: Curcumin (HOC6H3 (OCH3) CH=CHCO] 2CH2, molecular weight 368.38 (Bio Basic Canada Inc.), was dissolved in tween 80 (Sigma) and it was administered intraperitoneally (IP) at a dose of 50 mg/kg.
Some hypotheses suggest that compensatory mechanisms such as polycythemia and postural orthostatic tachycardia may be able to maintain sufficient tissue oxygen delivery during orthodeoxia, explaining the absence of acute platypnea [10, 11].
Thus, thromboses are a substantial contributor to symptom burden of MPN patients and impact on their life expectancies [58] as demonstrated by the largest epidemiologic study in PV (European Collaboration on Low dose Aspirin in Polycythemia vera, ECLAP), which showed cardiovascular events to account for 41% of all deaths [59].
His serum erythropoietin level, at 11.8 mIU/mL, was inappropriately high for his degree of polycythemia. Methemoglobin level was 0.5 percent.
Extramedullary hematopoiesis (EMH) occasionally occurs in patients exhibiting hematological disorders with decreased hematopoietic efficacy, such as myelofibrosis, thalassemia, and polycythemia vera.